Caring for infants with congenital heart disease and their families

R B Saenz1, D K Beebe, L C Triplett

  • 1Department of Family Medicine, University of Mississippi Medical Center, Jackson 39216, USA.

Insights

Congenital heart defects are categorized as acyanotic or cyanotic. Early detection through specific infant symptoms and appropriate follow-up care are crucial for managing these conditions.

Area of Science:

  • Pediatrics
  • Cardiology
  • Medical Genetics

Background:

  • Congenital heart defects (CHDs) are common birth abnormalities.
  • CHDs are broadly classified into acyanotic and cyanotic types.
  • Common acyanotic CHDs include VSD, ASD, and coarctation of the aorta.
  • Common cyanotic CHDs include tetralogy of Fallot and transposition of the great arteries.

Purpose of the Study:

  • To outline the classification and common types of congenital heart defects.
  • To highlight the primary concerns (CHF vs. hypoxia) associated with each category.
  • To guide healthcare providers in recognizing and managing CHDs in infants.

Main Methods:

  • Review of common acyanotic and cyanotic congenital heart lesions.
  • Identification of key clinical signs and symptoms suggestive of CHD in infants.
  • Discussion of recommended follow-up schedules and management considerations.

Main Results:

  • Acyanotic lesions primarily lead to congestive heart failure in infants.
  • Cyanotic lesions primarily cause hypoxia in infants.
  • Suspicion of CHD is warranted with feeding difficulties, tachypnea, sweating, subcostal recession, or poor growth.

Conclusions:

  • Early recognition of CHD symptoms in infants is critical.
  • Tailored follow-up care, including vaccinations, is essential.
  • Family support and physician guidance are vital for managing parental expectations and misconceptions.

Related Concept Videos

Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...